Beijing [China], July 4 (ANI): A research team led by Prof. SI Longlong from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences has proposed a new live-attenuated influenza vaccine approach -- generating proteolysis-targeting chimeric (PROTAC) influenza A virus as a live-attenuated vaccine by utilizing the endogenous ubiquitin-proteasome system of host cells to degrade viral proteins.